AGI-134

• Description :

  AGI-134 is a fully synthetic alpha-Gal glycolipid. AGI-134 invokes CD8+ T cell-mediated immunity. AGI-134 induces tumor cell destruction and phagocytosis[1].

• UNSPSC :

  12352005

• Target :

  Biochemical Assay Reagents

• Type :

  Reference compound

• Related Pathways :

  Others

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Cancer; Inflammation/Immunology

• Assay Protocol :

  https://www.medchemexpress.com/agi-134.html

• Solubility :

  10 mM in DMSO

• Smiles :

  OC[C@@H](O[C@H]([C@@H]([C@H]1O)NC(C)=O)OCCCNC(CCCCC(NCCOP(OC[C@@H](COC(CCCCCCC/C=C\CCCCCCCC)=O)OC(CCCCCCC/C=C\CCCCCCCC)=O)(O)=O)=O)=O)[C@H]1O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O[C@H]3O[C@@H]([C@@H]([C@@H]([C@H]3O)O)O)CO)O

• Molecular Formula :

  C70H126N3O26P

• Molecular Weight :

  1456.73

• References & Citations :

  [1]Irit Carmi LEVY, et al. Agi-134 combined with a checkpoint inhibitor for the treatment of solid tumors. WO2019229745A1. 2019.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  Phase 2

• CAS Number :

  [1821461-84-0]